1
|
Miller AD. Sense–antisense (complementary) peptide interactions and the proteomic code; potential opportunities in biology and pharmaceutical science. Expert Opin Biol Ther 2015; 15:245-67. [DOI: 10.1517/14712598.2015.983069] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
|
2
|
Piva M, Moreno JI, Jenkins FS, Smith JKA, Thomas JL, Montgomery C, Wilson CB, Sizemore RC. In vitro modulation of cytokine expression by enkephalin-derived peptides. Neuroimmunomodulation 2005; 12:339-47. [PMID: 16557034 DOI: 10.1159/000091127] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/01/2005] [Accepted: 05/17/2005] [Indexed: 01/10/2023] Open
Abstract
OBJECTIVE We have previously reported that low doses of [Met(5)]-enkephalin (YGGFM, met-enkephalin) and two of its derivatives (YGG and YG) enhanced and accelerated delayed-type hypersensitivity responses while much higher doses of these compounds suppressed these reactions. Since the underlying mechanisms by which this and other immunomodulatory effects occur have not been established, this report explores the in vitro modulation of Th1 and Th2 cytokine expression by these peptides. METHODS Murine splenocytes were stimulated with suboptimal concentrations of concanavalin A (ConA) in serum-free medium in the absence or presence of met-enkephalin, YGG, YG, [des-Tyr(1)]-met-enkephalin (GGFM), [D-Ala(2)], [D-Met(5)]-enkephalin or tyrosine (Y). Cell-conditioned supernatants were assayed for interferon-gamma (IFN-gamma), interleukin (IL)-2 and IL-4. Relative IFN-gamma and IL-2 mRNA levels were assessed by reverse transcription-polymerase chain reaction. The enhancing and suppressive effects of met-enkephalin and YG on IFN-gamma production were also tested in the presence of naloxone (Nx). RESULTS Met-enkephalin, YGG and YG modulated the in vitro production of IFN-gamma in a biphasic manner: stimulation at low doses and inhibition at high doses. At higher concentrations, met-enkephalin and YG also suppressed the production of IL-2 (type 1) and IL-4, a type 2 cytokine. Nx reversed the enhancing effect of met-enkephalin on IFN-gamma production without affecting its suppressive action or any of the immunomodulating effects of YG. The degradation-resistant analog [D-Ala(2)], [D-Met(5)]-enkephalin enhanced IFN-gamma production but did not suppress it. CONCLUSIONS YG, the minimal molecular requirement for enhancement and suppression of immune responses by these metabolites, appears to mediate exclusively an across-the-board suppression via low-affinity, nonclassical, nonopioid receptors.
Collapse
Affiliation(s)
- Marta Piva
- Department of Biological Sciences, Alcorn State University, MS 39096, USA
| | | | | | | | | | | | | | | |
Collapse
|
3
|
Narayan P, Tandon R, Haq W, Dhar MM, Singh VK. Inhibition of antigen specific lymphocyte proliferation and cytokine stimulation by peptidomimetic opioid compound. Int Immunopharmacol 2002; 2:751-7. [PMID: 12095165 DOI: 10.1016/s1567-5769(02)00011-5] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
In sequel to our preliminary observations with peptidomimetic opioid compounds, we have further investigated immunomodulatory activity of one peptidomimetic compound (Tyr-NH-CH2-CH2-O-Phe-NH2) with peripheral blood mononuclear cells (PBMCs) of healthy volunteers/tuberculosis patients. This peptidomimetic compound was evaluated for its effect on purified protein derivative (PPD) stimulated lymphocyte proliferation in vitro, production of Th1 and Th2 cytokines by ELISA and ribonuclease protection assay. Our study shows the immunosuppressive potential of above synthetic peptidomimetic compound. This compound inhibited PPD stimulated human lymphocyte proliferation and this inhibition was reversed by opioid receptor antagonist, naloxone. Its immunosuppressive effect was further demonstrated by inhibition of interleukin-9 (IL-9), IL-10 but failed to influence IL-2, IL-15 and interferon-y (IFN-gamma) in PPD stimulated human PBMCs.
Collapse
Affiliation(s)
- P Narayan
- Department of Immunology, Sanjay Gandhi Post-Graduate Institute of Medical Sciences, Lucknow, India
| | | | | | | | | |
Collapse
|
4
|
Baranyi L, Campbell W, Ohshima K, Fujimoto S, Boros M, Okada H. The antisense homology box: a new motif within proteins that encodes biologically active peptides. Nat Med 1995; 1:894-901. [PMID: 7585214 DOI: 10.1038/nm0995-894] [Citation(s) in RCA: 75] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Amphiphilic peptides approximately fifteen amino acids in length and their corresponding antisense peptides exist within protein molecules. These regions (termed antisense homology boxes) are separated by approximately fifty amino acids. Because many sense-antisense peptide pairs have been reported to recognize and bind to each other, antisense homology boxes may be involved in folding, chaperoning and oligomer formation of proteins. The antisense homology box-derived peptide CALSVDRYRAVASW, a fragment of human endothelin A receptor, proved to be a specific inhibitor of endothelin peptide (ET-1) in a smooth muscle relaxation assay. The peptide was able to block endotoxin-induced shock in rats as well. Our finding of endothelin receptor inhibitor among antisense homology box-derived peptides indicates that searching proteins for this new motif may be useful in finding biologically active peptides.
Collapse
MESH Headings
- Amino Acid Sequence
- Animals
- Computer Simulation
- DNA, Antisense/genetics
- Drug Design
- Endothelins/antagonists & inhibitors
- Endotoxins/toxicity
- Humans
- Models, Molecular
- Molecular Chaperones/chemistry
- Molecular Chaperones/genetics
- Molecular Sequence Data
- Muscle, Smooth, Vascular/drug effects
- Peptide Fragments/chemistry
- Peptide Fragments/genetics
- Peptide Fragments/pharmacology
- Protein Binding
- Protein Conformation
- Protein Folding
- Protein Structure, Tertiary
- Rats
- Receptor, Endothelin A
- Receptors, Endothelin/chemistry
- Receptors, Endothelin/genetics
- Sequence Homology, Amino Acid
- Shock, Septic/chemically induced
- Shock, Septic/prevention & control
- Structure-Activity Relationship
Collapse
Affiliation(s)
- L Baranyi
- Choju Medical Institute, Noyori Fukushimura Hospital, Toyohashi, Japan
| | | | | | | | | | | |
Collapse
|
5
|
Boersma CJ, Van Leeuwen FW. Technical aspects of opioid receptor localization: detection of opioid receptor proteins by immunocytochemistry or with a biotinylated dynorphin analog. J Neurosci Methods 1994; 51:217-27. [PMID: 8051952 DOI: 10.1016/0165-0270(94)90014-0] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
Opioid receptors were localized at the cellular level, using either anti-opioid receptor antibodies or a biotinylated opioid ligand. In addition, a simple method was developed for selection of second antisera on their potencies to detect particular monoclonal antibodies (mAbs). Most anti-opioid receptor antibodies tested were not able to recognize the opioid receptor in frozen or fixed tissue sections, which was in contrast with their ability to recognize opioid receptors in isolated membrane fractions. However, one batch of anti-idiotypic mAbs gave a good immunocytochemical staining. Distribution of immunoreactivity suggested that these antibodies recognized more than one opioid receptor subtype. After very short fixation times, staining with a biotinylated kappa-selective ligand (DAKLIB) could be observed in the neural and intermediate lobe of pituitary. This binding could be displaced by non-biotinylated DAKLI. The pattern of DAKLIB staining in the neural lobe had the appearance of binding to both nerve fibres and astrocytes. The present results show successful staining of tissue sections with anti-idiotypic antibodies and with a biotinylated ligand. The specificity is discussed in the light of control experiments, pharmacological data and previous studies.
Collapse
Affiliation(s)
- C J Boersma
- Graduate School Neurosciences Amsterdam, Netherlands Institute for Brain Research
| | | |
Collapse
|
6
|
Zagon IS, McLaughlin PJ. Production and characterization of polyclonal and monoclonal antibodies to the zeta (zeta) opioid receptor. Brain Res 1993; 630:295-302. [PMID: 8118696 DOI: 10.1016/0006-8993(93)90669-e] [Citation(s) in RCA: 33] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/28/2023]
Abstract
The opioid growth factor, [Met5]-enkephalin, is an inhibitory agent of cell proliferation and maturation that interacts with the zeta (zeta) opioid receptor to modulate growth. In order to learn more about this receptor, polyclonal and monoclonal antibodies were raised against binding subunits identified on two-dimensional gels by ligand blotting. Using Western blotting, the polyclonal antibodies and some of the monoclonal antibodies recognized all 4 binding polypeptides (32, 30, 17, and 16 kDa) in developing rat cerebellum; no reaction was recorded in adult cerebellum. In addition, other monoclonals were able to distinguish only certain subunits (e.g. 17 kDa). The monoclonal antibodies and their F(ab')2 fragments, as well as the polyclonal antibodies, blocked the binding of [3H][Met5]-enkephalin to preparations of developing cerebellum. Both the polyclonal and monoclonal antibodies immunoprecipitated zeta opioid binding polypeptides from 6-day-old cerebellar homogenates solubilized by the zwitterionic detergent, CHAPS. Immunocytochemistry performed with polyclonal antibodies showed immunoreactivity associated with proliferating and differentiating cerebellar cells, but no specific staining was detected in the adult cerebellum. These results have identified and characterized antibodies to the zeta opioid receptor, and the antibodies were used to localize this receptor; these antibodies will be valuable to further cellular and molecular studies.
Collapse
Affiliation(s)
- I S Zagon
- Department of Neuroscience and Anatomy, Pennsylvania State University, M.S. Hershey Medical Center, Hershey 17033
| | | |
Collapse
|
7
|
Mazumder S, Nath I, Dhar MM. Immunomodulation of human T cell responses with receptor selective enkephalins. Immunol Lett 1993; 35:33-8. [PMID: 8384598 DOI: 10.1016/0165-2478(93)90144-q] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023]
Abstract
The delta-opioid receptor selective [2-D-penicillamine-5-D-penicillamine] enkephalin (DPDPE) and the mu receptor selective Tyr-D-Orn-Phe-Asp-NH2 (TOPA) were found respectively, to have marked immunostimulant and immunosuppressant activities in both normal subjects and patients suffering from leprosy and tuberculosis. Antigen specific lymphoproliferation and numbers of rosette forming T cells were significantly (P < 0.05) enhanced on in vitro treatment with Met-enkephalin. This was further increased (P < 0.001) in the presence of the delta selective DPDPE. In contrast, treatment with mu selective TOPA inhibited lymphoproliferation substantially (P < 0.01) and rosette formation to a lesser extent.
Collapse
MESH Headings
- Adjuvants, Immunologic/pharmacology
- Amino Acid Sequence
- Enkephalin, D-Penicillamine (2,5)-
- Enkephalin, Methionine/pharmacology
- Enkephalins/chemistry
- Enkephalins/pharmacology
- Humans
- Immunosuppressive Agents/pharmacology
- In Vitro Techniques
- Leprosy/immunology
- Lymphocyte Activation/drug effects
- Molecular Sequence Data
- Opioid Peptides
- Peptides, Cyclic/pharmacology
- Receptors, Opioid, delta/drug effects
- Receptors, Opioid, delta/immunology
- Receptors, Opioid, mu/drug effects
- Receptors, Opioid, mu/immunology
- Rosette Formation
- T-Lymphocytes/drug effects
- T-Lymphocytes/immunology
- T-Lymphocytes/metabolism
- Tuberculosis, Pulmonary/immunology
Collapse
Affiliation(s)
- S Mazumder
- Department of Biotechnology, All India Institute of Medical Sciences, New Delhi
| | | | | |
Collapse
|
8
|
Abstract
Codons of noncoding DNA strands for peptides have been found to code for amino acids with hydropathic properties opposite to those of the native peptides. Synthetic peptides, designated as complementary peptides, with amino acid sequences coded by noncoding DNA strands of several peptide hormones have been shown to bind the native peptides. In some instances, antibodies to these complementary peptides have shown agonist or antagonist properties of the native hormones. In this study a peptide was synthesized based on codons complementary to messenger RNA for the carboxyl-terminal gastrin tetrapeptide. This complementary peptide bound radiolabeled human gastrin (G17). Antibodies to the complementary peptide competitively inhibited the binding of 125I-gastrin by canine fundic mucosal membrane preparations. These antibodies also showed gastrin agonist properties in that they stimulated canine gastric mucosal parietal cell [14C]aminopyrine uptake, used as an index of stimulation of gastric acid secretion. Competitive inhibition of 125I-gastrin binding by membrane receptors for gastrin and stimulation of [14C]-aminopyrine uptake by antibodies to the complementary peptide for the gastrin tetrapeptide are consistent with their recognition, binding, and occupancy of gastrin receptors.
Collapse
Affiliation(s)
- J E McGuigan
- Department of Medicine, University of Florida College of Medicine, Gainesville
| | | |
Collapse
|
9
|
Collagen binding site in collagenase can be determined using the concept of sense-antisense peptide interactions. J Biol Chem 1992. [DOI: 10.1016/s0021-9258(18)42279-x] [Citation(s) in RCA: 60] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/19/2022] Open
|
10
|
Fassina G, Consonni R, Zetta L, Cassani G. Design of hydropathically complementary peptides for Big Endothelin affinity purification. INTERNATIONAL JOURNAL OF PEPTIDE AND PROTEIN RESEARCH 1992; 39:540-8. [PMID: 1399274 DOI: 10.1111/j.1399-3011.1992.tb00286.x] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Molecular recognition between Big Endothelin (Big ET) and a computer generated peptide hydropathically complementary to Big ET[16-29] sequence has been studied by analytical high performance liquid affinity chromatography (HPLAC), circular dichroism (CD) and nuclear magnetic resonance (NMR) experiments. Specific binding was observed between solid support immobilized complementary peptide and Big ET[1-38], [1-32], and [16-32], but not with Big ET fragments [1-21], [16-21], [22-32], and [22-38], obtained by chymotrypsin proteolytic degradation. Selectivity in the recognition process was clearly demonstrated by the ability of complementary peptide affinity column to purify the Big ET molecule from complex peptide mixtures, even when present in very low concentrations. Similar selectivity was evidenced with the Big ET fragment [16-32], [NH2-HLDIIWVNTPEHIVPYG-COOH] containing the entire hydropathically complementary sequence. Binding was followed by marked spectroscopic changes, as monitored by circular dichroism and one- and two-dimensional nuclear magnetic resonance experiments. The NMR spectra of the complementary peptides 1:1 mixture showed variations in the chemical shifts of proton resonances in several residues, both in the main chain (amide protons) and in the side chains (aliphatic and aromatic protons). These data support the hypothesis of a multilocalized type of interaction between complementary peptides, where many residues along the peptide chains participate in co-operative stabilizing contacts in the forming complex.
Collapse
Affiliation(s)
- G Fassina
- Protein Engineering Unit, TECNOGEN S.c.p.A., Milan, Italy
| | | | | | | |
Collapse
|
11
|
Beattie J, Flint DJ. Critical evaluation of a theory of molecular recognition using human insulin-like-growth-factor-I fragment 21-40 and its complementary peptide. Biochem J 1992; 283 ( Pt 2):473-8. [PMID: 1374232 PMCID: PMC1131059 DOI: 10.1042/bj2830473] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
Using solid-phase methods we have synthesized human insulin-like-growth-factor-I (IGF-I) fragment 21-40 (IGF-I 21-40) and the peptide derived from the 5'----3' translation of the complementary nucleic acid of this peptide, 'I-FGI 20-40' (the complementary peptide). According to a recently proposed theory of molecular recognition, these two peptides should bind specifically to each other. We have tested this theory by using both solid- and solution-phase direct-binding assays for this complementary-peptide pair. We have also investigated the ability of I-FGI 20-40 to interfere with native IGF-I binding during radioimmunoassay (r.i.a.), radio-receptor (r.r.a.) assay and ligand-blot analysis of IGF-binding proteins. We have obtained no evidence of any interaction between IGF-I 21-40 and I-FGI 20-40 in either solid- or solution-phase assays. In addition, I-FGI 20-40 does not interfere in the assays used to detect IGF-I binding antibodies (r.i.a.), receptors (r.r.a.) or binding proteins (ligand blots). Our data therefore question the universality of this particular theory of molecular recognition.
Collapse
Affiliation(s)
- J Beattie
- Hannah Research Institute, Ayr, Scotland, U.K
| | | |
Collapse
|
12
|
Fassina G, Cassani G. Design and recognition properties of a hydropathically complementary peptide to human interleukin 1 beta. Biochem J 1992; 282 ( Pt 3):773-9. [PMID: 1554360 PMCID: PMC1130855 DOI: 10.1042/bj2820773] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
A computer-designed hydropathically complementary peptide to human interleukin 1 beta (IL1 beta) precursor sequence 204-215 recognized the 204-215 peptide as well the entire IL1 beta protein with binding affinities in the micromolar range. Interaction between the complementary pair was characterized by analytical high-performance liquid affinity chromatography on columns derivatized with the computer-generated peptide. Recognition selectivity was clearly shown by the ability of the computer-generated complementary peptide columns to purify the IL1 beta-(204-215)-peptide from complex synthetic mixtures with high yields, independently of the type of solid support used. Recognition specificity was demonstrated by the inability of the IL1 beta-(204-215)-peptide and IL1 beta molecules to interact with blank columns or columns derivatized with other non-related peptides. Furthermore, scrambling the sequence of the computer-generated peptide or the IL1 beta-(204-215)-peptide in such a way as to alter their hydropathic profiles had the effect of abolishing binding. The complementary pair failed to interact in the presence of competing peptide, thus providing further evidence of specificity. Computer-generated complementary peptide affinity columns also proved useful for purification of recombinant human IL1 beta protein directly from crude Escherichia coli lysates.
Collapse
Affiliation(s)
- G Fassina
- Protein Engineering Unit, TECNOGEN S.c.p.A., Milano, Italy
| | | |
Collapse
|
13
|
Kavelaars A, Ballieux RE, Heijnen CJ. Differential effects of beta-endorphin on cAMP levels in human peripheral blood mononuclear cells. Brain Behav Immun 1990; 4:171-9. [PMID: 1964616 DOI: 10.1016/0889-1591(90)90020-q] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/29/2022] Open
Abstract
In the present paper we demonstrate that one of the early effects of the opioid peptide beta-endorphin on human peripheral blood mononuclear cells is the induction of a change in the intracellular cAMP level. However, the effect of beta-endorphin on cAMP levels is not uniform; increases as well as decreases in cAMP level are observed. It appears that beta-endorphin is a true modulator of intracellular cAMP level: the peptide will increase cAMP levels in cells with a low baseline level. In contrast, beta-endorphin tends to decrease cAMP levels is cells with a high cAMP concentration. Moreover, beta-endorphin modulates the rise in cAMP induced by beta-adrenergic activation. The effect of beta-endorphin on cAMP level correlates negatively with the magnitude of the change in cAMP level induced by beta-adrenergic activation.
Collapse
Affiliation(s)
- A Kavelaars
- Department of Pediatric Immunology, University Hospital for Children and Youth Het Wilhelmina Kinderziekenhuis, Utrecht, The Netherlands
| | | | | |
Collapse
|
14
|
Clarke BL, Bost KL. A monoclonal anti-peptide antibody recognizes the adrenocorticotropic receptor. Biochem Biophys Res Commun 1990; 168:1020-6. [PMID: 2161212 DOI: 10.1016/0006-291x(90)91131-b] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
We have produced a monoclonal antibody that specifically recognizes the adrenocorticotropic receptor on rat adrenal cells. The immunogen was designed from an RNA sequence complementary to the mRNA coding for ACTH1-24. This complementary peptide, termed HTCA, has been shown to specifically bind ACTH and was proposed to mimic the ACTH binding site of the hormone receptor. The monoclonal anti-HTCA antibody recognized a restricted domain of the HTCA peptide, bound to Y-1 adrenal cells with a KD of 1.8 nM, and blocked the binding of 125I-ACTH to rat adrenal cells. These findings show that anti-HTCA competes with ACTH for binding to the ACTH receptor.
Collapse
MESH Headings
- Adrenal Medulla/cytology
- Adrenal Medulla/immunology
- Adrenal Medulla/metabolism
- Adrenocorticotropic Hormone/genetics
- Adrenocorticotropic Hormone/metabolism
- Amino Acid Sequence
- Animals
- Antibodies, Monoclonal/biosynthesis
- Antibodies, Monoclonal/immunology
- Antibodies, Monoclonal/metabolism
- Antibody Specificity
- Binding, Competitive
- Male
- Mice
- Mice, Inbred BALB C
- Oligopeptides/chemical synthesis
- Oligopeptides/immunology
- Oligopeptides/metabolism
- RNA, Messenger/genetics
- Rats
- Rats, Inbred Strains
- Receptors, Corticotropin
- Receptors, Pituitary Hormone/immunology
- Receptors, Pituitary Hormone/metabolism
Collapse
Affiliation(s)
- B L Clarke
- University of Alabama, Department of Physiology and Biophysics, Birmingham
| | | |
Collapse
|
15
|
Abstract
The observation that pairs of peptides encoded from complementary strands of nucleic acids can bind one another suggested to us that proteins might use similar "complementary peptide" sequences to facilitate their interactions with other proteins or peptides. Here we review evidence to support this hypothesis. Investigations by us and by others showed that receptors and their ligands may use complementary peptide sequences or their analogs to facilitate binding. In addition, antibodies made against pairs of complementary peptides bind one another in an idiotypic/anti-idiotypic fashion. Taken together, these findings suggest that complementary peptide sequences may be used as recognition units by pairs of proteins which interact.
Collapse
Affiliation(s)
- K L Bost
- Department of Physiology and Biophysics, University of Alabama, Birmingham
| | | |
Collapse
|